Cerebrospinal fluid biomarkers in cardiac arrest survivors

Resuscitation

Volumn 85, Issue 2, 2014, Pages 227-232

  Rosén, Christoffer ^a   Rosén, Hans ^a   Andreasson, Ulf ^a   Bremell, Daniel ^a   Bremler, Rosemary ^b   Hagberg, Lars ^a   Rosengren, Lars ^a   Blennow, Kaj ^a   Zetterberg, Henrik ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Karlstad Hospital   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomarkers; Cardiac arrest; Cerebrospinal fluid; Outcome

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; AMYLOID PRECURSOR PROTEIN BETA; MACROPHAGE INFLAMMATORY PROTEIN; NEUROFILAMENT LIGHT PROTEIN; NEUROFILAMENT PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADL DISABILITY; ADULT; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; LONG TERM CARE; LUMBAR PUNCTURE; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NERVE CELL LESION; OUT OF HOSPITAL CARDIAC ARREST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; SURVIVOR;

BIOMARKERS; CARDIAC ARREST; CEREBROSPINAL FLUID; OUTCOME;

ACTIVITIES OF DAILY LIVING; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; OUT-OF-HOSPITAL CARDIAC ARREST; SURVIVORS; TAU PROTEINS;

EID: 84892870306     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2013.10.032     Document Type: Article

References (30)

1. Berdowski J., Berg R.A., Tijssen J.G., Koster R.W. Global incidences of out-of-hospital cardiac arrest and survival rates: systematic review of 67 prospective studies. Resuscitation 2010, 81:1479-1487.
2. Young G.B. Clinical practice. Neurologic prognosis after cardiac arrest. N Engl J Med 2009, 361:605-611.
3. Chiota N.A., Freeman W.D., Barrett K.M. Hypoxic-ischemic brain injury and prognosis after cardiac arrest. Continuum (Minneap Minn) 2011, 17:1094-1118.
4. Norgren N., Rosengren L., Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res 2003, 987:25-31.
5. Nylen K., Csajbok L.Z., Ost M., et al. CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett 2006, 404:132-136.
6. Zetterberg H., Hietala M.A., Jonsson M., et al. Neurochemical aftermath of amateur boxing. Arch Neurol 2006, 63:1277-1280.
7. Hesse C., Rosengren L., Andreasen N., et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 2001, 297:187-190.
8. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
9. Ost M., Nylen K., Csajbok L., et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006, 67:1600-1604.
10. Craig-Schapiro R., Perrin R.J., Roe C.M., et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 2010, 68:903-912.
11. Perrin R.J., Craig-Schapiro R., Malone J.P., et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One 2011, 6:e16032.
12. Zetterberg H., Mortberg E., Song L., et al. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans. PLoS One 2011, 6:e28263.
13. Rosen H., Karlsson J.E., Rosengren L. CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci 2004, 221:19-24.
14. Vanderstichele H., Van Kerschaver E., Hesse C., et al. Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 2000, 7:245-258.
15. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease. Mol Chem Neuropathol 1995, 26:231-245.
16. Vanmechelen E., Vanderstichele H., Davidsson P., et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 2000, 285:49-52.
17. Zetterberg H., Andreasson U., Hansson O., et al. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 2008, 65:1102-1107.
18. Cummins R.O., Chamberlain D.A., Abramson N.S., et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 1991, 84:960-975.
19. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
20. Katz S., Ford A.B., Moskowitz R.W., Jackson B.A., Jaffe M.W. Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963, 185:914-919.
21. Franz G., Beer R., Kampfl A., et al. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 2003, 60:1457-1461.
22. Randall J., Mortberg E., Provuncher G.K., et al. Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation 2013, 84:351-356.
23. Olsson A., Csajbok L., Ost M., et al. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J Neurol 2004, 251:870-876.
24. Mehta P.D., Pirttila T., Mehta S.P., Sersen E.A., Aisen P.S., Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 2000, 57:100-105.
25. Hansson O., Zetterberg H., Vanmechelen E., et al. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 2010, 31:357-367.
26. Bell R.D., Rosenberg R.N., Ting R., Mukherjee A., Stone M.J., Willerson J.T. Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol 1978, 3:52-59.
27. Wijdicks E.F., Hijdra A., Young G.B., Bassetti C.L., Wiebe S. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 67:203-210.
28. Martens P., Raabe A., Johnsson Serum P. S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998, 29:2363-2366.
29. Rosen H., Sunnerhagen K.S., Herlitz J., Blomstrand C., Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001, 49:183-191.
30. Wojtczak-Soska K., Lelonek M. S-100B protein: an early prognostic marker after cardiac arrest. Cardiol J 2010, 17:532-536.